Cambrex to Announce Third Quarter 2015 Financial Results on November 3, 2015
Get Alerts CBM Hot Sheet
Join SI Premium – FREE
EAST RUTHERFORD, N.J., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) announced that third quarter 2015 financial results will be released on Tuesday, November 3, 2015 before the market opens.
The Company will host a conference call to discuss the financial results.
Third Quarter 2015 Earnings Conference Call | ||||||
When: | Tuesday, November 3, 2015 at 8:30 a.m. Eastern Time | |||||
Dial-in: | 1-800-723-6604 for U.S. | |||||
1-785-830-7977 for International | ||||||
Passcode: 6843322 | ||||||
Dial-in Replay: | 1-888-203-1112 for U.S. | |||||
1-719-457-0820 for International | ||||||
Passcode: 6843322 | ||||||
Available through Tuesday, November 10, 2015 | ||||||
Webcast: | www.cambrex.com | |||||
About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
Stephanie LaFiura Investor Relations Associate Phone: 201.804.3037 Email: [email protected]Source: Cambrex Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- Kiniksa Pharmaceuticals, Ltd. (KNSA) Misses Q1 EPS by 11c; raises guidance
- AGNC Investment Corp (AGNC) PT Lowered to $10.25 at Jones Trading
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!